Variant report
Variant | esv3353599 |
---|---|
Chromosome Location | chr14:104680903-104683469 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr14:104646912..104648600-chr14:104679599..104681696,2 | MCF-7 | breast: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs10141973 | chr14:104680936-104680937 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs539041382 | chr14:104680958-104680959 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs138763366 | chr14:104681002-104681003 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs569148735 | chr14:104681132-104681133 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs538370837 | chr14:104681140-104681141 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs554745150 | chr14:104681143-104681144 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs186535669 | chr14:104681148-104681149 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs10133496 | chr14:104681161-104681162 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs56176138 | chr14:104681180-104681181 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs201693392 | chr14:104681190-104681191 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs199767044 | chr14:104681214-104681215 | ZNF genes & repeats Weak transcription Enhancers Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
12 | rs111531721 | chr14:104681241-104681242 | ZNF genes & repeats Weak transcription Enhancers Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
13 | rs61996656 | chr14:104681263-104681264 | ZNF genes & repeats Weak transcription Enhancers Bivalent/Poised TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs576773797 | chr14:104681324-104681325 | ZNF genes & repeats Weak transcription Enhancers Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
15 | rs201550149 | chr14:104681326-104681327 | ZNF genes & repeats Weak transcription Enhancers Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
16 | rs191350524 | chr14:104681338-104681339 | ZNF genes & repeats Weak transcription Enhancers Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
17 | rs113497324 | chr14:104681351-104681352 | ZNF genes & repeats Weak transcription Enhancers Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
18 | rs562535298 | chr14:104681365-104681366 | ZNF genes & repeats Weak transcription Enhancers Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
19 | rs113871445 | chr14:104681383-104681384 | ZNF genes & repeats Weak transcription Enhancers Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
20 | rs531184249 | chr14:104681392-104681393 | ZNF genes & repeats Weak transcription Enhancers Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
21 | rs112300133 | chr14:104681406-104681407 | ZNF genes & repeats Weak transcription Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
22 | rs200290980 | chr14:104681416-104681417 | ZNF genes & repeats Weak transcription Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
23 | rs578074476 | chr14:104681434-104681435 | ZNF genes & repeats Weak transcription Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
24 | rs111174240 | chr14:104681438-104681439 | ZNF genes & repeats Weak transcription Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
25 | rs111174241 | chr14:104681444-104681445 | ZNF genes & repeats Weak transcription Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
26 | rs145863682 | chr14:104681476-104681477 | ZNF genes & repeats Weak transcription Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
27 | rs541929051 | chr14:104681482-104681483 | ZNF genes & repeats Weak transcription Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
28 | rs371029213 | chr14:104681489-104681490 | ZNF genes & repeats Weak transcription Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
29 | rs111063712 | chr14:104681508-104681509 | ZNF genes & repeats Weak transcription Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
30 | rs111172660 | chr14:104681515-104681516 | ZNF genes & repeats Weak transcription Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
31 | rs111164367 | chr14:104681523-104681524 | ZNF genes & repeats Weak transcription Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
32 | rs368706693 | chr14:104681531-104681532 | ZNF genes & repeats Weak transcription Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
33 | rs553960469 | chr14:104681547-104681548 | ZNF genes & repeats Weak transcription Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
34 | rs372245737 | chr14:104681552-104681553 | ZNF genes & repeats Weak transcription Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
35 | rs199864473 | chr14:104681572-104681573 | ZNF genes & repeats Weak transcription Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
36 | rs111217085 | chr14:104681574-104681575 | ZNF genes & repeats Weak transcription Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
37 | rs111861101 | chr14:104681581-104681582 | ZNF genes & repeats Weak transcription Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
38 | rs367986637 | chr14:104681588-104681589 | ZNF genes & repeats Weak transcription Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
39 | rs201568274 | chr14:104681596-104681597 | ZNF genes & repeats Weak transcription Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
40 | rs199668835 | chr14:104681600-104681601 | ZNF genes & repeats Weak transcription Bivalent/Poised TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs141383435 | chr14:104681614-104681615 | ZNF genes & repeats Weak transcription Bivalent/Poised TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs111172661 | chr14:104681622-104681623 | ZNF genes & repeats Weak transcription Bivalent/Poised TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs62639543 | chr14:104681628-104681629 | ZNF genes & repeats Weak transcription Bivalent/Poised TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs117028540 | chr14:104681632-104681633 | ZNF genes & repeats Weak transcription Bivalent/Poised TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs62644849 | chr14:104681638-104681639 | ZNF genes & repeats Weak transcription Bivalent/Poised TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs200208414 | chr14:104681648-104681649 | ZNF genes & repeats Weak transcription Bivalent/Poised TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs201293355 | chr14:104681663-104681664 | ZNF genes & repeats Weak transcription Bivalent/Poised TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs139237606 | chr14:104681667-104681668 | ZNF genes & repeats Weak transcription Bivalent/Poised TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs530329503 | chr14:104681675-104681676 | ZNF genes & repeats Weak transcription Bivalent/Poised TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs111206900 | chr14:104681690-104681691 | ZNF genes & repeats Weak transcription Bivalent/Poised TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal cancer | 21851588 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Retinoblastoma | 21504564 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Melanoma | 18172304 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Oral cancer | 21386901 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Neuroblastoma | 19435921 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Breast cancer | 17899364 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Gastrointestinal stromal cancer | 17535989 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Paraganglioma | 17535989 | CNVD |
Pulmonary chondroma | 17535989 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Chronic myeloid leukemia | 20724749 | CNVD |
Wilms tumour | 21544195 | CNVD |
Lung cancer | 18438408 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
cataract | 16735990 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
small cell lung cancer | 20016488 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Developmental delay | 21147756 | CNVD |
Cancer | 20164920 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Biliary cancer | 19435499 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Acute lymphoblastic leukemia | 20139093 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Non-small cell lung cancer | 18320023 | CNVD |
Melanoma | 17363583 | CNVD |
Prostate cancer | 18632612 | CNVD |
Congenital heart defect | 22367666 | CNVD |
Developmental delay | 22367666 | CNVD |
Genitourinary abnormalities | 22367666 | CNVD |
Intellectual disability | 22367666 | CNVD |
Microcephaly | 22367666 | CNVD |
Muscularhypotonia | 22367666 | CNVD |
Ocular coloboma | 22367666 | CNVD |
Teratozoospermia | 22367666 | CNVD |
Cervical cancer | 21062161 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Breast cancer | 21990379 | CNVD |
Breast cancer | 16417655 | CNVD |
22q11 deletion syndrome | 22511897 | CNVD |
Cancer | 21129771 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
Schizophrenia | 21399695 | CNVD |
Intracranial ependymoma | 16609018 | CNVD |
Lung adenocarcinoma | 17086460 | CNVD |
Gastric adenocarcinoma | 19115996 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
14q deletion syndrome | 22511897 | CNVD |
Epilepsy | 22083797 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Cancer | 17440070 | CNVD |
Neurocytoma | 17123091 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Central neurocytomas | 17123091 | CNVD |
Acute lymphoblastic leukemia | 17315016 | CNVD |
Lung cancer | 17086460 | CNVD |
Mortal | 21835882 | CNVD |
Breast cancer | 21364760 | CNVD |
small cell lung cancer | 17426248 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Ependymoma | 20639864 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Ependymoma | 19289631 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
T-cell lymphomas | 22341440 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr14:104677000-104681800 | Weak transcription | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
2 | chr14:104677800-104685000 | Weak transcription | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
3 | chr14:104680400-104681200 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
4 | chr14:104680400-104681600 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
5 | chr14:104681000-104681400 | Enhancers | Fetal Intestine Small | intestine |
6 | chr14:104681200-104681400 | Enhancers | Duodenum Mucosa | Duodenum |
7 | chr14:104681200-104682000 | Bivalent/Poised TSS | Gastric | stomach |
8 | chr14:104681200-104682200 | ZNF genes & repeats | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
9 | chr14:104681600-104681800 | Enhancers | Spleen | Spleen |
10 | chr14:104681600-104682000 | ZNF genes & repeats | iPS DF 19.11 Cell Line | embryonic stem cell |
11 | chr14:104681800-104682000 | ZNF genes & repeats | Pancreas | Pancrea |
12 | chr14:104681800-104682200 | ZNF genes & repeats | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
13 | chr14:104682000-104682200 | Active TSS | Gastric | stomach |
14 | chr14:104682000-104684200 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
15 | chr14:104682000-104688400 | Weak transcription | Pancreas | Pancrea |
16 | chr14:104682200-104684400 | Weak transcription | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
17 | chr14:104682400-104682600 | Bivalent/Poised TSS | Foreskin Melanocyte Primary Cells skin01 | Skin |
18 | chr14:104682800-104683000 | Bivalent Enhancer | Foreskin Melanocyte Primary Cells skin01 | Skin |
19 | chr14:104682800-104683000 | Bivalent Enhancer | Fetal Stomach | stomach |